Loading company…
Shanghai-based biotech company founded in 2003 that develops HPV vaccines aimed at preventing cervical cancer.
Shanghai Zerun Biotechnology Co., Ltd., established in 2003 and based in Shanghai, China, develops HPV vaccines aimed at preventing cervical cancer, with 2-valent and 9-valent products in its pipeline. Its founder, Dr. Shi Li, previously worked 13 years at Merck and is an inventor of the 4-valent and 9-valent HPV vaccines on the market. As of 2024 the company held 35 domestic and 22 international invention patents. In December 2019 it closed a round of strategic investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in